CINECA IRIS Institutional Research Information System

CERUTI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.657
EU - Europa 4.685
AS - Asia 2.255
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 9
OC - Oceania 7
Totale 12.656
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.625
CN - Cina 1.003
IT - Italia 775
IE - Irlanda 727
DE - Germania 680
SE - Svezia 589
FI - Finlandia 453
KR - Corea 414
UA - Ucraina 407
JP - Giappone 299
FR - Francia 292
SG - Singapore 256
VN - Vietnam 208
PL - Polonia 179
GB - Regno Unito 178
AT - Austria 147
DK - Danimarca 120
IN - India 43
RU - Federazione Russa 43
NL - Olanda 30
CA - Canada 29
BE - Belgio 23
SN - Senegal 23
EU - Europa 13
UZ - Uzbekistan 12
IR - Iran 10
GR - Grecia 8
AU - Australia 6
BR - Brasile 6
CZ - Repubblica Ceca 6
ES - Italia 4
HU - Ungheria 4
RO - Romania 4
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CH - Svizzera 2
MX - Messico 2
MY - Malesia 2
RS - Serbia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
HK - Hong Kong 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
SI - Slovenia 1
TW - Taiwan 1
Totale 12.656
Salva come PNG Salva come JPEG
Città #
Chandler 747
Beijing 742
Ann Arbor 730
Dublin 725
Jacksonville 422
Dearborn 300
Princeton 234
Houston 183
Boston 181
Dong Ket 177
Warsaw 174
Wilmington 171
Ashburn 165
Villeurbanne 156
Fairfield 151
Vienna 147
Medford 146
Singapore 144
Torino 127
Woodbridge 115
Frankfurt am Main 97
Nyköping 95
Munich 79
Fremont 74
Boardman 65
Seattle 64
Milan 63
Cambridge 54
Pisa 45
New York 34
Hefei 32
Falls Church 31
Rome 29
Norwalk 28
Kunming 26
Santa Clara 24
Verona 24
Redwood City 23
Nanjing 21
Brussels 19
Guangzhou 18
Washington 17
Düsseldorf 15
Helsinki 15
Moscow 15
Nanchang 15
Buffalo 14
Cimitile 14
Hebei 12
San Mateo 12
Hangzhou 11
Phoenix 11
Pune 11
Toronto 11
Zhengzhou 11
Harbin 9
Chongqing 8
Palermo 8
Shanghai 8
Wuhan 8
Fuzhou 7
Lachine 7
San Diego 7
Tulsa 7
Bari 6
Hanover 6
Jinan 6
Paderno Dugnano 6
Shenyang 6
Dallas 5
Loreto 5
Los Angeles 5
Mountain View 5
Napoli 5
Shenzhen 5
Turin 5
Ardabil 4
Aversa 4
Brescia 4
Changsha 4
Lavagna 4
Leawood 4
London 4
Matsuyama 4
Monmouth Junction 4
Philadelphia 4
Recife 4
Redmond 4
Ruda Śląska 4
University Park 4
West Jordan 4
Bologna 3
Budapest 3
Castello di Godego 3
Des Moines 3
Hamilton 3
Iesi 3
Kharkiv 3
Lucca 3
Lugo 3
Totale 7.287
Salva come PNG Salva come JPEG
Nome #
Carbammati lipidici di farmaci antitumorali. 431
Antifungal activity of bis-azasqualenes, inhibitors of oxidosqualene cyclase 208
Farmaci macromolecolari: veicolazione e direzionamento mediante albumina umana 188
Study of (1-alkoxyethyl)diphenylphosphine oxides. I. Syntheses and structural analyses of phenylethoxy, methoxy and isopentyloxy derivatives. 179
Robinia “Georgia da Torino”. 173
1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis[1,2,4]triazolo[4,3-a:3’,4’-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties 162
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 153
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase. 148
Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells 146
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae 144
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase 140
10 and 19-azasqualene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase from pig liver. 136
Comparison of experimental and molecular modelling results on phosphine oxides. 133
Study of (1-alkoxyethyl)diphenylphosphine oxides. IV. Conclusive conformational study by NMR and molecular mechanics calculations. 125
Study of (1-alkoxyethyl)diphenylphosphine oxides. II. Conformational analysis by theoretical calculations. 124
A Simple Synthesis and some Chemical Properties of Benzo-1,4-dithiafulvenes 123
Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy 121
Study of (1-alkoxyethyl)diphenylphosphine oxides. III. Nuclear magnetic resonance analysis. 118
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases 117
Synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives as Inhibitors of Liver and Yeast Oxidosqualene Cyclase. 111
[Antiproliferative effect of an extract of Aspergillus terreus] 109
Sintesi di inibitori suicidi dello squalene 2,3-epossido ciclasi. 104
Studio del metabolismo in vivo nel ratto dell'antiparkinson Budipina. 102
Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry 101
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae. 98
Structure and reactivity of the dammarenyl cation: configurational transmission in triterpene synthesis 97
Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett technique 96
Sintesi di aldeidi per omologazione di composti carbonilici, via 1,4-benzoditiafulveni. 92
An NMR and molecular mechanics study of squalene and squalene derivatives 90
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 89
Synthesis and biological activity of 22,23-epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide - lanosterol cyclase. 87
Synthesis of a squalenoid oxaziridine and other new classes of squalene derivatives, as inhibitors of sterol biosynthesis. 84
Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface 83
2,3-oxidosqualene cyclase and squalene epoxidase: enzymology, mechanism and inhibitors 82
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 81
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors 80
New DSPE-PEG-Folate conjugates for liposomal drug targeting 79
N-oxide as a potential function in the design of enzyme inhibitors. Application to 2,3-epoxysqualene-sterol cyclases. 79
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors. 77
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae 76
2-Aza-2,3-dihydrosqualene: biodistribution and pharmacokinetic properties in mice. 76
Azasqualeni N-ossidi e bis-azasqualeni, inibitori dell'enzima squalene epossido ciclasi. 76
The squalene-2,3-epoxide cyclase as a model for the development of new drugs. 75
Synthesis, characterization and biological activity of new cationic lipids active for gene transfection. 75
Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae. 75
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase. 75
2,3-oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 74
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. 74
The metabolic fate of the anti-parkinsonian drug budipine in rats. 73
Bis(2-Acyloxy or Aroylxybenzenethiolates)Mercury (II) as Inhibitors of “Fusarium” 72
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 72
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase. 72
Total synthesis of the hypocholesterolemic and antifungal drug 10-azasqualene 2,3-epoxide, the first non-cyclized analogue of the C-8 carbonium ion formed during squalene epoxide cyclization. 72
2,3,4,5-Tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 72
A new "solid phase" procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates). 72
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody. 71
2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase. 71
Synthesis of HEI analogues of the C-20 carbocation forming during lanosterol biosynthesis, as hypocholesterolemics. 71
2,3-Oxidosqualene cyclase and squalene epoxidase as target enzymes for the development of new sterol biosynthesis inhibitors 71
A convenient synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 71
Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives. 70
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 69
The in vitro metabolism of 1,3-thiazolidine derivatives of theophylline: a study on structure-metabolism correlation. 69
Synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 68
Synthesis of new gemcitabine prodrugs for liposome and nanoparticle encapsulation 68
Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives. 68
Synthesis of tritium-labelled 19-azasqualene 2,3-epoxide and derivatives, as probes to study their hypocholesterolemic activity. 68
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase 68
Antifungal and cytotoxic activiti of two inhibitors of 2,3-oxidosqualene cyclase 67
22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase. 66
Azasqualene alcohol and derivatives. New selective inhibitors of 2,3-oxidosqualene cyclase. 66
2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 65
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase. 65
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids 63
Sostanze mutagene e cancerogene in funghi del genere Agaricus. 62
Biocompatible micelles based on amphiphilic polyaspartamide-squalene derivatives as potential colloidal drug carriers. 62
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study. 62
Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique 61
(E) and (Z)-29-methylidene-2,3-oxidosqualene as stereospecific mechanism-based inhibitors of 2,3-oxidosqualene cyclase. 61
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. 61
Studio comparato dell'attività inibitoria di derivati squalenoidi acetilenici ed allenici, nei confronti dell'enzima squalene epossidasi e delle monoossigenasi P-450 dipendenti. 61
Rational inhibition of sterol biosynthesis: new time-dependent inhibitors of 2,3-oxidosqualene cyclase. 60
Total synthesis and inhibition of sterol biosynthesis by 10-azasqualene 2,3-epoxide, a high-energy intermediate analogue 59
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 59
Metabolismo ossidativo di funzioni acetaliche e tioacetaliche cicliche: studio della correlazione struttura metabolismo. 59
An NMR and molecular mechanics study of squalene and squalene derivatives. 58
Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase. 58
Studio del metabolismo del 7-(1,3-ditiolan-2-ilmetil)teofillina, un nuovo farmaco ad attività antibroncospastica e mucolitica. 58
Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes. Evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage. 57
Sintesi ed attività biologica di azasqualeni, bis-azasqualeni e derivati. 57
Incorporation of lipophilic gemcitabine prodrugs in liposomes 57
Preparation, characterization, cytotoxicity and pharmacokinetcs of liposomes containing lipophilic gemcitabine prodrugs 56
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 56
Synthesis and inhibition of cholesterol biosynthesis by azasqualene alcohol and derivatives. 56
1H-NMR and 13C-NMR studies for the assignment of the structure of (6E)-10-azasqualene 2,3-epoxide and (6Z)-10-azasqualene 2,3-epoxide and their correlation with hypocholesterolemic and antifungal activity. 56
2-Aza-2,3-dihydrosqualene and its N-oxide as inhibitors of sterol biosynthesis in bramble cell suspension cultures. 55
An NMR study of 2-aza and 19-azasqualene derivatives. Primo Congresso Congiunto Italiano-Svizzero di Chimica Farmaceutica, 55
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. 54
Synthesis and antibronchospastic activity of theophylline thioacetal derivatives. 53
Antifungal spectrum of two acyclic inhibitors of 2,3-oxidosqualene cyclase. 53
Totale 8.872
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.045
article - articoli 0
book - libri 0
conference - conferenze 14.479
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.847 0 0 229 127 114 345 275 89 266 172 143 87
2020/20211.410 182 49 86 70 127 73 117 37 140 96 126 307
2021/20221.901 71 56 66 139 114 65 144 138 60 140 391 517
2022/20232.335 295 133 37 235 212 697 245 122 212 17 97 33
2023/2024893 140 182 54 30 51 92 19 36 3 44 63 179
2024/2025135 28 107 0 0 0 0 0 0 0 0 0 0
Totale 13.269